MIRA Pharmaceuticals Inc. (NASDAQ: MIRA)
$0.75
+0.0100 ( +1.35% ) 1.4M
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Market Data
Open
$0.75
Previous close
$0.74
Volume
1.4M
Market cap
$11.97M
Day range
$0.64 - $0.83
52 week range
$0.51 - $7.98
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 12, 2024 |
8-k | 8K-related | 14 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 14 | May 29, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
10-q | Quarterly Reports | 48 | May 13, 2024 |
10-k | Annual reports | 84 | Apr 01, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |